How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?
J Clin Oncol
; : JCO2400566, 2024 Jul 31.
Article
in En
| MEDLINE
| ID: mdl-39083709
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Oncol
Year:
2024
Document type:
Article
Affiliation country: